Vijay Patel

Dr. Vijay Patel

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
BOB.S. Oberman
B.S. Oberman
VPVijay Patel
Vijay Patel
SCS. Cureoglu
S. Cureoglu
HIHüseyin Işıldak
Hüseyin Işıldak
La Sindrome di Ménière, una condizione descritta nel 1800, è stata un’area di grande interesse clinico e di ricerca scientifica negli ultimi decenni. Le linee guida pubblicate dall’ American Academy of Otolaryngology-Head and Neck Surgery sono rimaste pressoché invariate per quasi 20 anni, benché la ricerca scientifica sugli aspetti eziopatologici sia indubbiamente molto progredita nel frattempo. La presente revisione della letteratura evidenzia gli importanti progressi compiuti nella comprensione della fisiopatologia di questa malattia enigmatica. Le evidenze discusse sono inoltre accompagnate da una documentazione iconografica istopatologica. L’obiettivo della presente trattazione è fornire al lettore un quadro aggiornato ed accurato sulle teorie inerenti la Sindrome di Ménière.

9 April 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
DBDarrin Bann
Darrin Bann
VPVijay Patel
Vijay Patel
RSRobert A. Saadi
Robert A. Saadi
JGJohn P. Gniady
John P. Gniady
NGNeerav Goyal
Neerav Goyal
DGDavid Goldenberg
David Goldenberg

1 August 2017 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
VPVijay Patel
Vijay Patel
MCMichele M Carr
Michele M Carr

16 April 2020 in Head & Neck
Verified
Journal Article
Open access
PDF file
MHMax Hennessy
Max Hennessy
DBDarrin Bann
Darrin Bann
VPVijay Patel
Vijay Patel
RSRobert A. Saadi
Robert A. Saadi
GKGreg A. Krempl
Greg A. Krempl
KCKaren Y. Choi
Karen Y. Choi
The coronavirus disease‐2019 (COVID‐19) pandemic has rapidly spread across the world, placing unprecedented strain on the health care system. Health care resources including hospital beds, ICUs, as well as personal protective equipment are becoming increasingly rationed and scare commodities. In this environment, the laryngectomee (patient having previously undergone a total laryngectomy) continues to represent a unique patient with unique needs. Given their surgically altered airway, they pose a challenge to manage for the otolaryngologist within the current COVID‐19 pandemic. In this brief report, we present special considerations and best practice recommendations in the management of total laryngectomy patients. We also discuss recommendations for laryngectomy patients and minimizing community exposures.

11 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SCSonja Chen
Sonja Chen
RURuben Ulloa
Ruben Ulloa
JSJustin Soffer
Justin Soffer
RARoberto Javier Alcazar-Felix
Roberto Javier Alcazar-Felix
CSCarl H. Snyderman
Carl H. Snyderman
SPSean P Polster
Sean P Polster
This systematic review aims to characterize ongoing clinical trials and therapeutic treatment options for chordoma, a rare notochordal remnant tumor that primarily affects the cranial base, mobile spine, and sacrum. While radical surgical resection remains the cornerstone for chordoma management, unique technical challenges posed by its proximity to critical neurovascular structures confer a tendency towards disease recurrence which often requires additional treatment modalities. In an attempt to better understand the current treatment landscape, a systematic review was designed to identify clinical trials directed at chordoma. A total of 108 chordoma trials were identified from four clinical trial databases; fifty-one trials were included in the final analysis, of which only 14 were designated as completed (27.5%). Aggregate data suggests most chordoma interventions are repurposed from other neoplasms that share common molecular pathways, with a recent emphasis on combination therapeutics within and across drug classes. Naturally, the publication and dissemination of clinical trial results remain a concern (n = 4, 28.6%), highlighting the need for enhanced reporting and transparency measures. Active clinical trial efforts are quite promising, with a renewed focus on novel biotherapeutic targets and deciphering the natural history, as well as survivorship of this complex disease.

1 December 2018 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
PDF file
VPVijay Patel
Vijay Patel
MDM. Dunklebarger
M. Dunklebarger
TZT. T. Zacharia
T. T. Zacharia
HIHüseyin Işıldak
Hüseyin Işıldak
Susac syndrome, a rare autoimmune disorder first described as a classic triad (encephalopathy, branch retinal artery occlusion, and sensorineuralhearing loss) in 1979 by renowned physician John O. Susac, has been an advancing area of clinical interest and scientific researchover the last several decades. This comprehensive review aims to succinctly highlight the breadth and detail of this enigmatic disease, witha primary focus on otologic manifestations. Topics discussed include epidemiology, pathophysiology, clinical manifestations, differentialdiagnoses, classification schema, laboratory investigations, characteristic audiometric findings, high-yield radiographic imaging, temporalbone histopathology, treatment strategies and overall prognosis.